Amphastar Pharmaceuticals, Inc. (AMPH) › Total LiabilitiesAmphastar Pharmaceuticals, Inc. (AMPH) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2013: $87.20M2014: $107.51M2015: $94.63M2016: $98.48M2017: $117.34M2018: $149.20M2019: $159.44M2020: $182.51M2021: $226.01M2022: $213.33M2023: $873.49M2024: $845.17M2025: $840.49M$840.49M2013Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$840.49M-0.6%2024$845.17M-3.2%2023$873.49M+309.5%2022$213.33M-5.6%2021$226.01M+23.8%2020$182.51M+14.5%2019$159.44M+6.9%2018$149.20M+27.2%2017$117.34M+19.1%2016$98.48M+4.1%2015$94.63M-12.0%2014$107.51M+23.3%2013$87.20M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share